drugset / Trial / NCT06935149
Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools
Phase 1
Completed
5 enrolled
Primo Biotechnology Co., Ltd.
Kaoshiung Chang Gung Memorial Hospital · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This study will demonstrate the diagnostic utility of PSMA PET among patients with CRC with liver metastasis.
Timeline
- Start
- 2025-10-31
- Primary completion
- 2026-04-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18-PSMA | Diagnostic / imaging agent | 4 mbq/kg | Intravenous |